AI/ML Innovations Inc.

Toronto, ON. – January 12, 2021, AI/ML Innovations Inc. (“ AIML ” or the “ Company ”) announces that it has effective January 11, 2021, granted consultants an aggregate of 900,000 stock options at $0.40 pursuant to its stock option plan, subject to the policies of the CSE. The Options vest immediately and are exercisable until September 30, 2021.

About Health Gauge

Health Gauge’s patent-pending solution is a personal health monitoring & management system, which combines the latest wearable health monitors with sophisticated artificial intelligence software tools and proprietary cloud computing software, to help caregivers, patients, and healthcare professionals access and utilize relevant data, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

Health Gauge is currently working to develop strategic partnerships with leading channel partners, health benefits providers, and end-users. Its products have completed beta testing in 2020 are expected to be commercially available and implemented during the first quarter of 2021.

About AI/ML Innovations Inc.

AI/ML Innovations Inc. has focused its business operations to capitalize on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol "AIML". For detailed information please see AI/ML's website at https://aiml-innovations.com.

Contact

For further information, contact Blake Fallis at [email protected] or [email protected] or 250-384-1999.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

- Cautionary and Forward Looking Statements

Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the uncertainty of competition by other industry players, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals and the ability to raise additional capital as may be needed in the future. Readers are cautioned that the assumptions used in preparing such information, although considered reasonable at the time of preparation, may prove imprecise and undue reliance should not be placed on forward-looking statements. Forward-looking statements in this press release are expressly qualified by this cautionary statement.

The forward-looking statements in this press release are made as of the date of this press release, and the Company undertakes no obligations to update publicly or to revise any of the included forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.

NATDOCS\51156447\V-2

AI assistant

AI/ML Innovations Inc. Capital/Financing Update 2021

43967_rns_2021-01-12_160097ff-06db-49e7-9822-8a7cda07bc36.pdf